GenomOncology announced it will integrate Pacific Biosciences’ HiFi whole-genome sequencing secondary analysis pipeline into its Pathology Workbench reporting platform. The workflow combines research-use-only secondary genome analysis with Pathology Workbench’s tertiary processes including quality control, variant interpretation, and report generation. GenomOncology said the goal is to standardize long-read WGS upstream steps while tailoring downstream reports for tumor types and clinical or reimbursement needs, with initial attention on myeloid-focused use cases.